Sara Nayeem
New Enterprise Associates Partner
location
Washington, District of Columbia
investment range
$200k - $40.0m
sweet spot
$10.0m
Sara Nayeem's Past Investments (8)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Centrexion | Series D | $67M (Lead) | Jan 2018 | |
| Complexa | Series C | $62M (Lead) | Jul 2017 | |
| Mersana Therapeutics | Series C | $33M | Jun 2016 | |
| TESARO | Post-IPO Equity | $155M (Lead) | Mar 2016 | |
| Mersana Therapeutics | Series B | $35M (Lead) | Mar 2015 | |
| Mersana Therapeutics | Series A | $14.5M | Apr 2014 | |
| TESARO | Series B | $101M | Jun 2011 | |
| TESARO | Series A | $60M (Lead) | May 2010 |
Sara Nayeem's Experience
Partner New Enterprise Associates (NEA)2015 - Present
Principal New Enterprise Associates (NEA)2010 - 2015
Principal New Enterprise Associates2010 - 2015
Senior Associate New Enterprise Associates2009 - 2009
Senior Associate New Enterprise Associates (NEA)2009 - 2009
Investment Banking Associate Merrill Lynch2006 - 2009
Investment Banking Analyst Morgan Stanley1999 - 2001
Sara Nayeem's Education
Yale University MD / MBA
Harvard University AB Biological Sciences
Sara Nayeem's Media
No media found for Sara Nayeem.